Absolute 0 8 0 8 B-clinical_variable
Neutrophil 9 19 9 19 I-clinical_variable
Count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1,500 34 39 34 39 B-lower_bound
/ 39 40 39 40 I-lower_bound
mm3 40 43 40 43 I-lower_bound

Albumin 0 7 44 51 B-clinical_variable
> 8 9 52 53 O
25 10 12 54 56 B-lower_bound
g 13 14 57 58 I-lower_bound
/ 14 15 58 59 I-lower_bound
L 15 16 59 60 I-lower_bound

All 0 3 61 64 O
acute 4 9 65 70 O
toxic 10 15 71 76 O
effects 16 23 77 84 O
of 24 26 85 87 O
any 27 30 88 91 O
prior 31 36 92 97 B-treatment
treatment 37 46 98 107 I-treatment
have 47 51 108 112 O
resolved 52 60 113 121 O
to 61 63 122 124 O
NCI 64 67 125 128 B-clinical_variable
- 67 68 128 129 I-clinical_variable
CTCAE 68 73 129 134 I-clinical_variable
v4.0 74 78 135 139 O
Grade 79 84 140 145 B-upper_bound
1 85 86 146 147 I-upper_bound
or 87 89 148 150 O
less 90 94 151 155 O
at 95 97 156 158 O
the 98 101 159 162 O
time 102 106 163 167 O
of 107 109 168 170 O
signing 110 117 171 178 O
the 118 121 179 182 O
Informed 122 130 183 191 O
Consent 131 138 192 199 O
Form 139 143 200 204 O
( 144 145 205 206 O
ICF 145 148 206 209 O
) 148 149 209 210 O

Any 0 3 211 214 O
infection 4 13 215 224 B-chronic_disease
≥ 14 15 225 226 O
National 16 24 227 235 O
Cancer 25 31 236 242 O
Institute 32 41 243 252 O
Common 42 48 253 259 O
Terminology 49 60 260 271 O
Criteria 61 69 272 280 O
for 70 73 281 284 O
Adverse 74 81 285 292 O
Events 82 88 293 299 O
( 89 90 300 301 O
NCI 90 93 301 304 O
- 93 94 304 305 O
CTCAE 94 99 305 310 O
) 99 100 310 311 O
version 101 108 312 319 O
4.03 109 113 320 324 O
Grade 114 119 325 330 O
2 120 121 331 332 O

Any 0 3 333 336 O
other 4 9 337 342 O
serious 10 17 343 350 B-chronic_disease
illness 18 25 351 358 I-chronic_disease
or 26 28 359 361 O
medical 29 36 362 369 B-chronic_disease
condition 37 46 370 379 I-chronic_disease

Any 0 3 380 383 O
size 4 8 384 388 O
pelvic 9 15 389 395 O
lymphadenopathy 16 31 396 411 B-chronic_disease
if 32 34 412 414 O
it 35 37 415 417 O
is 38 40 418 420 O
thought 41 48 421 428 O
to 49 51 429 431 O
be 52 54 432 434 O
a 55 56 435 436 O
contributor 57 68 437 448 O
to 69 71 449 451 O
concurrent 72 82 452 462 O
hydronephrosis 83 97 463 477 B-chronic_disease

Aspartate 0 9 478 487 B-clinical_variable
aminotransferase 10 26 488 504 I-clinical_variable
( 27 28 505 506 I-clinical_variable
AST 28 31 506 509 I-clinical_variable
) 31 32 509 510 I-clinical_variable
and 33 36 511 514 O
alanine 37 44 515 522 B-clinical_variable
aminotransferase 45 61 523 539 I-clinical_variable
( 62 63 540 541 I-clinical_variable
ALT 63 66 541 544 I-clinical_variable
) 66 67 544 545 I-clinical_variable
≤ 68 69 546 547 O
2.5 70 73 548 551 B-upper_bound
x 74 75 552 553 I-upper_bound
ULN 76 79 554 557 I-upper_bound

Bone 0 4 558 562 O
- 4 5 562 563 O
predominant 5 16 563 574 O
metastatic 17 27 575 585 O
CRPC 28 32 586 590 B-cancer
: 32 33 590 591 O
at 34 36 592 594 O
least 37 42 595 600 O
two 43 46 601 604 B-lower_bound
skeletal 47 55 605 613 B-cancer
metastases 56 66 614 624 I-cancer
on 67 69 625 627 O
bone 70 74 628 632 B-treatment
scan 75 79 633 637 I-treatment
with 80 84 638 642 O
no 85 87 643 645 O
lung 88 92 646 650 B-cancer
, 92 93 650 651 O
liver 94 99 652 657 B-cancer
, 99 100 657 658 O
and/or 101 107 659 665 O
brain 108 113 666 671 B-cancer
metastasis 114 124 672 682 I-cancer
( 125 126 683 684 O
lymph 126 131 684 689 B-cancer
node 132 136 690 694 I-cancer
metastasis 137 147 695 705 I-cancer
is 148 150 706 708 O
allowed 151 158 709 716 O
) 158 159 716 717 O

Cardiac 0 7 718 725 B-clinical_variable
failure 8 15 726 733 I-clinical_variable
New 16 19 734 737 I-clinical_variable
York 20 24 738 742 I-clinical_variable
Heart 25 30 743 748 I-clinical_variable
Association 31 42 749 760 I-clinical_variable
( 43 44 761 762 I-clinical_variable
NYHA 44 48 762 766 I-clinical_variable
) 48 49 766 767 I-clinical_variable
III 50 53 768 771 B-lower_bound
or 54 56 772 774 O
IV 57 59 775 777 B-upper_bound

Creatinine 0 10 778 788 B-clinical_variable
≤ 11 12 789 790 O
1.5 13 16 791 794 B-upper_bound
x 17 18 795 796 I-upper_bound
ULN 19 22 797 800 I-upper_bound

Crohn 0 5 801 806 B-chronic_disease
's 5 7 806 808 I-chronic_disease
disease 8 15 809 816 I-chronic_disease
or 16 18 817 819 O
ulcerative 19 29 820 830 B-chronic_disease
colitis 30 37 831 838 I-chronic_disease

ECOG 0 4 839 843 B-clinical_variable
performance 5 16 844 855 I-clinical_variable
status 17 23 856 862 I-clinical_variable
of 24 26 863 865 O
zero 27 31 866 870 B-lower_bound
, 31 32 870 871 O
one 33 36 872 875 O
, 36 37 875 876 O
or 38 40 877 879 O
two 41 44 880 883 B-upper_bound

Fecal 0 5 884 889 B-chronic_disease
incontinence 6 18 890 902 I-chronic_disease

Hemoglobin 0 10 903 913 B-clinical_variable
( 11 12 914 915 I-clinical_variable
HGB 12 15 915 918 I-clinical_variable
) 15 16 918 919 I-clinical_variable
≥10 17 20 920 923 O
g 21 22 924 925 I-lower_bound
/ 22 23 925 926 I-lower_bound
dl 23 25 926 928 I-lower_bound
( 26 27 929 930 O
Please 27 33 930 936 O
note 34 38 937 941 O
: 38 39 941 942 O
it 40 42 943 945 O
is 43 45 946 948 O
acceptable 46 56 949 959 O
from 57 61 960 964 O
the 62 65 965 968 O
standpoint 66 76 969 979 O
of 77 79 980 982 O
study 80 85 983 988 O
eligibility 86 97 989 1000 O
to 98 100 1001 1003 O
undergo 101 108 1004 1011 O
transfusion 109 120 1012 1023 O
in 121 123 1024 1026 O
order 124 129 1027 1032 O
to 130 132 1033 1035 O
achieve 133 140 1036 1043 O
hemoglobin 141 151 1044 1054 B-clinical_variable
≥ 152 153 1055 1056 O
10 154 156 1057 1059 O
g 157 158 1060 1061 O
/ 158 159 1061 1062 O
dl 159 161 1062 1064 O
) 161 162 1064 1065 O

Histologically 0 14 1066 1080 O
or 15 17 1081 1083 O
cytologically 18 31 1084 1097 O
confirmed 32 41 1098 1107 O
adenocarcinoma 42 56 1108 1122 B-cancer
of 57 59 1123 1125 I-cancer
the 60 63 1126 1129 I-cancer
prostate 64 72 1130 1138 I-cancer

Imminent 0 8 1139 1147 O
spinal 9 15 1148 1154 B-chronic_disease
cord 16 20 1155 1159 I-chronic_disease
compression 21 32 1160 1171 I-chronic_disease
based 33 38 1172 1177 O
on 39 41 1178 1180 O
clinical 42 50 1181 1189 O
findings 51 59 1190 1198 O
and/or 60 66 1199 1205 O
magnetic 67 75 1206 1214 B-treatment
resonance 76 85 1215 1224 I-treatment
imaging 86 93 1225 1232 I-treatment
( 94 95 1233 1234 I-treatment
MRI 95 98 1234 1237 I-treatment
) 98 99 1237 1238 I-treatment

Judged 0 6 1239 1245 O
by 7 9 1246 1248 O
investigator 10 22 1249 1261 O
to 23 25 1262 1264 O
have 26 30 1265 1269 O
progressive 31 42 1270 1281 B-chronic_disease
disease 43 50 1282 1289 I-chronic_disease
sufficient 51 61 1290 1300 O
to 62 64 1301 1303 O
clinically 65 75 1304 1314 O
justify 76 83 1315 1322 O
standard 84 92 1323 1331 B-treatment
- 92 93 1331 1332 I-treatment
of 93 95 1332 1334 I-treatment
- 95 96 1334 1335 I-treatment
care 96 100 1335 1339 I-treatment
radium-223 101 111 1340 1350 I-treatment
treatment 112 121 1351 1360 I-treatment

Known 0 5 1361 1366 O
bone 6 10 1367 1371 B-chronic_disease
marrow 11 17 1372 1378 I-chronic_disease
dysplasia 18 27 1379 1388 I-chronic_disease

Life 0 4 1389 1393 B-clinical_variable
expectancy 5 15 1394 1404 I-clinical_variable
of 16 18 1405 1407 O
at 19 21 1408 1410 O
least 22 27 1411 1416 O
6 28 29 1417 1418 B-lower_bound
months 30 36 1419 1425 I-lower_bound

Lymphadenopathy 0 15 1426 1441 B-chronic_disease
exceeding 16 25 1442 1451 O
6 26 27 1452 1453 B-lower_bound
cm 28 30 1454 1456 I-lower_bound
in 31 33 1457 1459 O
short 34 39 1460 1465 O
- 39 40 1465 1466 O
axis 40 44 1466 1470 O
diameter 45 53 1471 1479 O

Male 0 4 1480 1484 B-gender
age 5 8 1485 1488 B-age
≥ 9 10 1489 1490 O
18 11 13 1491 1493 B-lower_bound
years 14 19 1494 1499 I-lower_bound

No 0 2 1500 1502 O
intention 3 12 1503 1512 O
to 13 15 1513 1515 O
use 16 19 1516 1519 O
cytotoxic 20 29 1520 1529 B-treatment
chemotherapy 30 42 1530 1542 I-treatment
within 43 49 1543 1549 O
the 50 53 1550 1553 O
next 54 58 1554 1558 B-upper_bound
6 59 60 1559 1560 I-upper_bound
months 61 67 1561 1567 I-upper_bound

Other 0 5 1568 1573 O
malignancy 6 16 1574 1584 B-cancer
treated 17 24 1585 1592 O
within 25 31 1593 1599 O
the 32 35 1600 1603 O
last 36 40 1604 1608 B-upper_bound
3 41 42 1609 1610 I-upper_bound
years 43 48 1611 1616 I-upper_bound

Platelet 0 8 1617 1625 B-clinical_variable
( 9 10 1626 1627 I-clinical_variable
PLT 10 13 1627 1630 I-clinical_variable
) 13 14 1630 1631 I-clinical_variable
count 15 20 1632 1637 I-clinical_variable
≥ 21 22 1638 1639 O
100,000 23 30 1640 1647 B-lower_bound
/ 30 31 1647 1648 I-lower_bound
mm3 31 34 1648 1651 I-lower_bound

Presence 0 8 1652 1660 O
of 9 11 1661 1663 O
brain 12 17 1664 1669 B-cancer
metastases 18 28 1670 1680 I-cancer

Received 0 8 1681 1689 O
any 9 12 1690 1693 O
investigational 13 28 1694 1709 O
compound 29 37 1710 1718 O
within 38 44 1719 1725 O
28 45 47 1726 1728 B-upper_bound
days 48 52 1729 1733 I-upper_bound
prior 53 58 1734 1739 I-upper_bound
to 59 61 1740 1742 O
the 62 65 1743 1746 O
first 66 71 1747 1752 O
dose 72 76 1753 1757 O
of 77 79 1758 1760 O
study 80 85 1761 1766 B-treatment
drug 86 90 1767 1771 I-treatment
or 91 93 1772 1774 O
planned 94 101 1775 1782 O
during 102 108 1783 1789 O
the 109 112 1790 1793 O
treatment 113 122 1794 1803 B-treatment
period 123 129 1804 1810 O
or 130 132 1811 1813 O
follow 133 139 1814 1820 O
- 139 140 1820 1821 O
up 140 142 1821 1823 O

Received 0 8 1824 1832 O
previous 9 17 1833 1841 B-treatment
radiotherapy 18 30 1842 1854 I-treatment
to 31 33 1855 1857 O
approximately 34 47 1858 1871 O
> 48 49 1872 1873 O
25 49 51 1873 1875 B-lower_bound
% 51 52 1875 1876 I-lower_bound
of 53 55 1877 1879 O
bone 56 60 1880 1884 O
marrow 61 67 1885 1891 O

Received 0 8 1892 1900 O
systemic 9 17 1901 1909 B-treatment
therapy 18 25 1910 1917 I-treatment
with 26 30 1918 1922 I-treatment
radionuclides 31 44 1923 1936 I-treatment
( 45 46 1937 1938 O
e.g. 46 50 1938 1942 O
, 50 51 1942 1943 O
strontium-89 52 64 1944 1956 B-treatment
, 64 65 1956 1957 O
samarium-153 66 78 1958 1970 B-treatment
, 78 79 1970 1971 O
rhenium-186 80 91 1972 1983 B-treatment
, 91 92 1983 1984 O
or 93 95 1985 1987 O
rhenium-188 96 107 1988 1999 B-treatment
, 107 108 1999 2000 O
or 109 111 2001 2003 O
Radium 112 118 2004 2010 B-treatment
Ra 119 121 2011 2013 I-treatment
223 122 125 2014 2017 I-treatment
dichloride 126 136 2018 2028 I-treatment
) 136 137 2028 2029 O
for 138 141 2030 2033 O
the 142 145 2034 2037 O
treatment 146 155 2038 2047 B-treatment
of 156 158 2048 2050 O
bony 159 163 2051 2055 B-cancer
metastases 164 174 2056 2066 I-cancer

Regular 0 7 2067 2074 O
use 8 11 2075 2078 O
of 12 14 2079 2081 O
analgesic 15 24 2082 2091 B-treatment
medication 25 35 2092 2102 I-treatment
for 36 39 2103 2106 O
cancer 40 46 2107 2113 B-cancer
- 46 47 2113 2114 I-cancer
related 47 54 2114 2121 I-cancer
bone 55 59 2122 2126 I-cancer
pain 60 64 2127 2131 I-cancer
( 65 66 2132 2133 O
≥ 66 67 2133 2134 O
level 68 73 2135 2140 B-lower_bound
1 74 75 2141 2142 I-lower_bound
; 75 76 2142 2143 O
WHO 77 80 2144 2147 O
ladder 81 87 2148 2154 O
for 88 91 2155 2158 O
cancer 92 98 2159 2165 O
pain 99 103 2166 2170 O
) 103 104 2170 2171 O

Subjects 0 8 2172 2180 O
must 9 13 2181 2185 O
agree 14 19 2186 2191 B-contraception_consent
to 20 22 2192 2194 I-contraception_consent
use 23 26 2195 2198 I-contraception_consent
adequate 27 35 2199 2207 I-contraception_consent
contraception 36 49 2208 2221 I-contraception_consent
beginning 50 59 2222 2231 O
at 60 62 2232 2234 O
the 63 66 2235 2238 O
signing 67 74 2239 2246 O
of 75 77 2247 2249 O
the 78 81 2250 2253 O
ICF 82 85 2254 2257 O
until 86 91 2258 2263 O
at 92 94 2264 2266 O
least 95 100 2267 2272 O
6 101 102 2273 2274 B-lower_bound
months 103 109 2275 2281 I-lower_bound
after 110 115 2282 2287 I-lower_bound
the 116 119 2288 2291 O
last 120 124 2292 2296 O
dose 125 129 2297 2301 O
of 130 132 2302 2304 O
study 133 138 2305 2310 B-treatment
drug 139 143 2311 2315 I-treatment

Total 0 5 2316 2321 B-clinical_variable
bilirubin 6 15 2322 2331 I-clinical_variable
level 16 21 2332 2337 I-clinical_variable
≤ 22 23 2338 2339 O
1.5 24 27 2340 2343 B-upper_bound
x 28 29 2344 2345 I-upper_bound
institutional 30 43 2346 2359 I-upper_bound
upper 44 49 2360 2365 I-upper_bound
limit 50 55 2366 2371 I-upper_bound
of 56 58 2372 2374 I-upper_bound
normal 59 65 2375 2381 I-upper_bound
( 66 67 2382 2383 I-upper_bound
ULN 67 70 2383 2386 I-upper_bound
) 70 71 2386 2387 I-upper_bound

Treatment 0 9 2388 2397 B-treatment
should 10 16 2398 2404 O
be 17 19 2405 2407 O
completed 20 29 2408 2417 O
for 30 33 2418 2421 O
spinal 34 40 2422 2428 O
cord 41 45 2429 2433 O
compression 46 57 2434 2445 O

Treatment 0 9 2446 2455 B-treatment
with 10 14 2456 2460 I-treatment
EBRT 15 19 2461 2465 I-treatment
for 20 23 2466 2469 O
bone 24 28 2470 2474 O
pain 29 33 2475 2479 O
( 34 35 2480 2481 O
though 35 41 2481 2487 O
EBRT 42 46 2488 2492 O
must 47 51 2493 2497 O
be 52 54 2498 2500 O
completed 55 64 2501 2510 O
≥12 65 68 2511 2514 O
weeks 69 74 2515 2520 I-lower_bound
prior 75 80 2521 2526 I-lower_bound
to 81 83 2527 2529 O
enrollment 84 94 2530 2540 O
in 95 97 2541 2543 O
this 98 102 2544 2548 O
trial 103 108 2549 2554 O
) 108 109 2554 2555 O

Treatment 0 9 2556 2565 B-treatment
with 10 14 2566 2570 O
cytotoxic 15 24 2571 2580 B-treatment
chemotherapy 25 37 2581 2593 I-treatment
within 38 44 2594 2600 O
previous 45 53 2601 2609 B-upper_bound
28 54 56 2610 2612 I-upper_bound
days 57 61 2613 2617 I-upper_bound
, 61 62 2617 2618 O
or 63 65 2619 2621 O
failure 66 73 2622 2629 O
to 74 76 2630 2632 O
recover 77 84 2633 2640 O
from 85 89 2641 2645 O
AEs 90 93 2646 2649 O
due 94 97 2650 2653 O
to 98 100 2654 2656 O
cytotoxic 101 110 2657 2666 O
chemotherapy 111 123 2667 2679 O
administered 124 136 2680 2692 O
more 137 141 2693 2697 O
than 142 146 2698 2702 O
28 147 149 2703 2705 O
days 150 154 2706 2710 O
previous 155 163 2711 2719 O
( 164 165 2720 2721 O
however 165 172 2721 2728 O
, 172 173 2728 2729 O
ongoing 174 181 2730 2737 O
neuropathy 182 192 2738 2748 O
is 193 195 2749 2751 O
permitted 196 205 2752 2761 O
) 205 206 2761 2762 O

Visceral 0 8 2763 2771 B-cancer
metastases 9 19 2772 2782 I-cancer
as 20 22 2783 2785 O
assessed 23 31 2786 2794 O
by 32 34 2795 2797 O
abdominal 35 44 2798 2807 B-treatment
or 45 47 2808 2810 O
pelvic 48 54 2811 2817 B-treatment
computed 55 63 2818 2826 I-treatment
tomography 64 74 2827 2837 I-treatment
( 75 76 2838 2839 I-treatment
CT 76 78 2839 2841 I-treatment
) 78 79 2841 2842 I-treatment
or 80 82 2843 2845 O
other 83 88 2846 2851 O
imaging 89 96 2852 2859 O
modality 97 105 2860 2868 O

White 0 5 2869 2874 B-clinical_variable
Blood 6 11 2875 2880 I-clinical_variable
Cell 12 16 2881 2885 I-clinical_variable
Count 17 22 2886 2891 I-clinical_variable
( 23 24 2892 2893 I-clinical_variable
WBC 24 27 2893 2896 I-clinical_variable
) 27 28 2896 2897 I-clinical_variable
≥ 29 30 2898 2899 O
3,000 31 36 2900 2905 B-lower_bound
/ 36 37 2905 2906 I-lower_bound
mm3 37 40 2906 2909 I-lower_bound

